
Decdan 0.5 Tablet
Wockhardt Ltd - tablet - 10 Tablet
Standard delivery
Distributor inventory
Human insulin (biphasic) 30% soluble insulin + 70% isophane (NPH) insulin, 40 IU/mL
Diabetes mellitus (Type 1 and Type 2) requiring insulin therapy; control of blood glucose levels
Biphasic human insulin provides a quick onset from soluble insulin and a longer, intermediate effect from NPH insulin. It replaces/augments endogenous insulin to increase peripheral glucose uptake and reduce hepatic glucose production, thereby lowering blood sugar.
For subcutaneous injection only, as prescribed by the doctor. Usually injected 15–30 minutes before meals; dose and timing are individualized. Roll vial gently to resuspend (do not shake vigorously); use insulin syringes suitable for U-40 strength; rotate injection sites.
Common side effects of Wosulin 30/70 40IU may include:

Wockhardt Ltd - tablet - 10 Tablet
Standard delivery
Wockhardt Ltd - injection - 1 ml - 1 S
Standard delivery

Wockhardt Ltd - tablet - 4 S
Standard delivery

Wockhardt Ltd - 100 iu - 1 S
Standard delivery
Wockhardt Ltd - 5 X3 ml
Standard delivery

Wockhardt Ltd - 14 S
Standard delivery

Wockhardt Ltd - 14 S
Standard delivery

Wockhardt Ltd - tablet - 15 S
Standard delivery
Risk of severe hypoglycaemia—monitor blood glucose regularly and carry fast-acting sugar. Do not use during episodes of hypoglycaemia. Use with caution in renal/hepatic impairment, elderly, irregular meals, increased exercise, or acute illness; dose adjustments may be needed. Do not mix with other insulins unless advised; ensure correct strength (U-40) to avoid dosing errors. Seek urgent care for severe allergy or recurrent unexplained hypoglycaemia.